Why Does Inflammation Cause Insomnia?

Peripheral inflammation causes insomnia primarily through the vagus nerve. Inflammatory cytokines like TNF-alpha and IL-1-beta activate vagal sensory neurons that relay signals to the brainstem nucleus tractus solitarius within minutes — faster than blood-borne pathways. Animal vagotomy studies confirm this: severing the vagus nerve blocks inflammation-driven sleep changes at physiologically relevant doses. In humans, two nights of disrupted sleep activate TLR4-stimulated monocyte production of TNF-alpha, with a trend toward increased IL-6.

Most people know that inflammation and poor sleep are connected, but not how inflammation signals travel from the body to the brain. The vagus nerve is the primary relay — a dedicated neural pathway that transmits cytokine information from peripheral organs to the brainstem faster than any blood-borne route. This article covers the vagal afferent pathway: how peripheral inflammation reaches the brain through the vagus nerve and disrupts sleep architecture. It does not cover general inflammation-sleep connections or how to reduce inflammation through diet or supplements. Inflammation-driven sleep disruption is one of several autonomic causes of poor sleep. The full autonomic picture is covered in the parent pillar article on autonomic sleep disruption.

How Does Inflammation in Your Body Reach Your Brain?

Inflammation reaches your brain through a dedicated nerve pathway — the vagus nerve. Vagal sensory neurons in your gut and organs detect cytokines like TNF-alpha and IL-1-beta, then transmit that information to the brainstem nucleus tractus solitarius within minutes. Recent research shows individual vagal neurons can distinguish between different cytokines, sending a specific inflammatory fingerprint to the brain.

The vagus nerve is the longest cranial nerve in the body, running from the brainstem to the gut and major organs. Its sensory fibers — called afferents — detect inflammatory molecules produced during immune activation and transmit that information to the nucleus tractus solitarius (NTS) in the brainstem. The NTS then projects to the hypothalamus, limbic structures, and sleep-regulatory regions, providing the anatomical substrate for translating peripheral immune signals into coordinated behavioral and physiological responses (Maier et al., 1998).

This neural route is considerably faster than the alternative humoral pathway, where cytokines travel through the bloodstream and enter the brain through circumventricular organs — areas that lack a complete blood-brain barrier. Because the vagal route operates on the order of minutes rather than hours, it explains why sickness behavior — including sleep changes — begins rapidly after peripheral immune activation.

A 2025 study using in vivo calcium imaging of vagal sensory neurons in anesthetized mice demonstrated that vagal neurons do not simply relay a generic inflammation alarm (Huerta et al., 2025). Individual neurons in the nodose ganglion — the cluster of vagal sensory cell bodies — showed selective responses to single cytokines (IL-1-beta, TNF, or IL-10), while other neurons encoded multiple cytokines with distinct temporal activity patterns. The nodose ganglion performs cytokine identity discrimination at the very first neural station in the body-brain axis, meaning the NTS receives a compositional immune fingerprint rather than a binary on-off signal.

Calcium imaging of vagal sensory neurons responding to specific cytokines — Individual nodose ganglia sensory neurons respond in a cytokine-specific manner. Huerta, T. S., Chen, A. C., Chaudhry, S., Tynan, A., Morgan, T., Park, K., Adamovich-Zeitlin, R., Haider, B., Li, J. H., Nagpal, M., Zanos, S., Pavlov, V. A., Brines, M., Zanos, T. P., Chavan, S. S., Tracey, K. J., & Chang, E. H. (2025). Neural representation of cytokines by vagal sensory neurons. *Nature Communications*, 16(1), 3840. https://pubmed.ncbi.nlm.nih.gov/40268933/

Single-cell RNA sequencing has further mapped the molecular identity of these vagal neuron subpopulations. A 2024 study published in Nature identified TRPA1- and CALCA-expressing vagal sensory neurons as a key subpopulation that communicates inflammatory cytokine signals to DBH-expressing neurons in the caudal nucleus of the solitary tract (cNST) (Jin et al., 2024). Pro-inflammatory and anti-inflammatory cytokines activated distinct vagal neuron subpopulations, confirming that the vagus nerve carries differentiated immune information rather than a single undifferentiated danger signal.

The clinical relevance of the vagal pathway over the humoral pathway comes down to dose. The vagal route dominates at low cytokine concentrations — the kind produced during chronic, low-grade inflammation from conditions like gut dysbiosis, metabolic dysfunction, or autoimmune activity. These are precisely the inflammatory states most commonly associated with chronic insomnia. Only at high cytokine concentrations — during severe infection or sepsis — does the humoral pathway through circumventricular organs become the dominant route.

Does Cutting the Vagus Nerve Block Inflammation-Driven Sleep Changes?

Yes. Three independent vagotomy studies in mice and rats confirm that severing the vagus nerve blocks inflammation-driven sleep changes at physiologically relevant cytokine doses. At low doses of TNF-alpha or IL-1-beta — the kind produced during everyday chronic inflammation — vagotomy blocked or significantly attenuated the brain cytokine increases and NREM sleep changes that intact animals showed.

The strongest evidence that the vagus nerve is the causal relay between peripheral inflammation and sleep disruption comes from vagotomy experiments — studies where the vagus nerve is surgically severed and the downstream effects on sleep are measured.

Zielinski et al., 2013: Vagotomized and sham-operated mice received peripheral injections of TNF-alpha at three doses (0.5, 1, and 3 micrograms per mouse) and LPS at three doses (0.05, 0.1, and 1 microgram per mouse). Vagotomy significantly attenuated TNF-alpha- and LPS-enhanced NREM sleep, with the attenuation most pronounced at the lower dose. Vagotomy also reduced brain IL-1-beta and TNF-alpha mRNA expression following peripheral TNF-alpha administration, directly demonstrating that vagal afferents mediate the peripheral-to-brain cytokine mRNA induction that drives NREM sleep enhancement. REM sleep and EEG delta power suppression were comparable between vagotomized and sham animals, showing specificity of the vagal pathway for NREM sleep and brain cytokine gene upregulation rather than global sleep-wake effects (Zielinski et al., 2013).

Kubota et al., 2001: Rats received intraperitoneal TNF-alpha at four doses (10, 50, 100, and 200 micrograms per kilogram). The NREM sleep increases produced by 50 or 100 micrograms per kilogram were significantly attenuated in vagotomized rats compared to sham-operated controls. However, the 200 microgram per kilogram dose produced similar NREM sleep enhancement in both groups — establishing the dose-dependent transition from vagal to humoral signaling routes. EEG delta power augmentation was abolished in vagotomized animals, demonstrating that vagal afferents are required for the cortical synchronizing effect of peripheral TNF-alpha (Kubota et al., 2001).

Hansen and Krueger, 1997: Rats received IL-1-beta at three doses (0.1, 0.5, and 2.5 micrograms per kilogram). At the lowest dose (0.1 micrograms per kilogram), NREM sleep increases and fever were fully blocked by subdiaphragmatic vagotomy. At 0.5 micrograms per kilogram, NREM sleep was significantly attenuated and fever was completely blocked. At 2.5 micrograms per kilogram, responses were virtually identical in both groups — high peripheral IL-1-beta accessed the brain via blood-borne pathways through circumventricular organs (Hansen & Krueger, 1997).

These three studies converge on a dose-dependent dual pathway principle: low-grade chronic inflammation signals the brain through the vagal route, while acute severe inflammation uses the humoral route. This distinction matters for understanding everyday insomnia because chronic low-grade inflammation — from gut permeability, metabolic syndrome, or persistent low-level immune activation — produces cytokine concentrations that fall squarely in the dose range where the vagus nerve is the dominant relay. The vagal pathway is not a backup system; for the type of inflammation most people experience, the vagal pathway is the primary route by which the brain learns about peripheral immune activation and alters sleep architecture in response.

What Happens to Sleep When Peripheral Inflammation Activates the Vagal Relay?

When inflammatory cytokines activate the vagal relay, the brain responds by increasing NREM sleep pressure and fragmenting sleep architecture. In a human trial of 95 healthy adults, just two nights of disrupted sleep activated TLR4-mediated monocyte production of TNF-alpha (P=0.03), with a trend toward increased IL-6 (P=0.09). A meta-analysis of 887 people confirmed that three or more consecutive nights of short sleep significantly elevate both IL-6 and C-reactive protein.

The relationship between inflammation and sleep runs in both directions. Peripheral inflammation drives sleep changes through the vagal relay, and disrupted sleep drives more peripheral inflammation — creating a self-reinforcing feedback loop that makes chronic insomnia progressively harder to break.

A 2023 randomized crossover trial provides the clearest human evidence for the sleep-to-inflammation direction of this loop. Irwin et al. randomized 95 healthy adults to two nights of forced awakening (an 8-hour sleep opportunity divided into intervals with scheduled awakenings that reduced maximum total sleep time to approximately 280 minutes per night) versus two nights of undisturbed sleep. Forced awakening significantly reduced N3 slow-wave sleep (P<0.001) and increased TLR4-stimulated monocyte production of TNF-alpha (P=0.03) with a trend toward increased IL-6 (P=0.09) -- the same cytokines that activate vagal afferents in animal models. Causal mediation analysis attributed 34.9% of the total effect of sleep disruption on downstream pain sensitivity to the combined pathway through N3 sleep loss and cellular inflammation (Irwin et al., 2023).

The magnitude and timeline of sleep-driven inflammation were quantified in a 2026 meta-analysis. Ballesio et al. analyzed 35 experimental studies involving 887 healthy human participants and found that multiple nights of partial sleep deprivation (approximately 4.3 hours per night for three or more consecutive nights) significantly elevated IL-6 (Cohen’s d=0.42, P<0.01) and C-reactive protein (d=0.76, P=0.03). Single-night total sleep deprivation produced no significant changes in any inflammatory marker examined (Ballesio et al., 2026).

The three-night threshold is clinically significant. A single bad night does not measurably activate peripheral inflammation, but three or more consecutive nights of restricted sleep — a pattern common in chronic insomnia — produces IL-6 and CRP elevations in the concentration range where vagal afferents respond in animal models. The dose-response pattern (chronic partial sleep restriction producing inflammation while acute total deprivation does not) provides a human parallel to the dose-dependent vagal cytokine signaling thresholds established in the vagotomy experiments: sustained, moderate cytokine elevations — not acute spikes — are what the vagal relay preferentially detects and transmits to the brain in animal studies.

The result is a compounding loop: three or more nights of poor sleep elevate peripheral cytokines, those cytokines activate vagal afferents that signal the NTS, and the NTS-driven response alters sleep architecture further — producing more nights of poor sleep that generate more peripheral inflammation. This feedback mechanism explains why chronic insomnia tends to worsen over time without intervention, and why addressing only one side of the loop (either inflammation or sleep alone) often produces incomplete results.

Can Vagus Nerve Stimulation Stop the Inflammation Signal?

The brain does not just receive inflammation reports through the vagus nerve — it sends anti-inflammatory signals back. A 2024 Nature study mapped a body-brain circuit where activating specific vagal neurons suppressed pro-inflammatory cytokines and rescued mice from lethal sepsis. However, a meta-analysis of over 1,100 humans found that vagus nerve stimulation devices have not consistently lowered inflammatory markers in people.

The vagal-NTS axis is not a passive sensory relay. It is a bidirectional regulatory circuit that both senses peripheral inflammation and actively modulates the immune response.

Jin et al. (2024) mapped this bidirectional circuit in Nature. They identified TRPA1/CALCA vagal neurons projecting to DBH neurons in the caudal nucleus of the solitary tract (cNST) as the key circuit nodes. Silencing this circuit produced uncontrolled peripheral inflammatory responses. Activating it suppressed pro-inflammatory cytokines and enhanced anti-inflammatory IL-10 (P<0.01-0.03 across measures). Targeted circuit activation rescued mice from otherwise lethal LPS-induced sepsis and significantly reduced DSS-induced colitis severity. The vagal-cNST axis actively determines the magnitude and inflammatory character of peripheral immune responses -- meaning the brain is not merely informed about inflammation but participates in controlling it.

Immune responses activate the brain via the vagal-brain axis. Jin, H., Li, M., Jeong, E., Castro-Martinez, F., & Zuker, C. S. (2024). A body-brain circuit that regulates body inflammatory responses. *Nature*, 630(8017), 695-703. https://pubmed.ncbi.nlm.nih.gov/38692285/

However, translating this animal evidence to humans has not succeeded. Schiweck et al. (2024) conducted a pre-registered systematic review and meta-analysis of 36 clinical studies enrolling 1,135 participants (780 receiving vagus nerve stimulation, 355 controls). Pooled meta-analyses found no significant reduction in key cytokines: short-term TNF-alpha (Hedges’ g=-0.21, P=0.359), short-term IL-6 (g=-0.94, P=0.112), long-term TNF-alpha (g=-0.13, P=0.196), and long-term IL-6 (g=-0.67, P=0.306). Only a subgroup of 4 long-term acute inflammation studies showed significant CRP reduction favoring VNS over sham (Schiweck et al., 2024).

The translational gap likely reflects a specificity problem. Animal studies activate precisely defined vagal neuron subpopulations — TRPA1/CALCA neurons projecting to specific cNST targets — while human VNS devices stimulate the entire vagus nerve trunk without subpopulation selectivity. The molecular mapping of distinct vagal neuron types suggests that broad-spectrum stimulation may simultaneously activate pro-inflammatory and anti-inflammatory vagal subpopulations, canceling out net effects.

A 2024 study adds another dimension to vagal dysfunction. Hofmann et al. demonstrated that vagotomy triggers pre- and postsynaptic remodeling in the NTS: presynaptic reduction in calcium channel activation at vagal terminals, and postsynaptic downregulation of NMDA (NR1) receptors. Vagotomy blunted cardiorespiratory responses to NMDA nanoinjection into the NTS, confirming that the postsynaptic NMDA receptor changes are functionally significant. Vagal dysfunction does not merely remove input — it restructures how remaining signals are processed at the NTS relay station (Hofmann et al., 2024). This remodeling has implications for chronic conditions that impair vagal function: the NTS may permanently alter its signal processing capacity, degrading the precision of immune-to-brain communication even if vagal input partially recovers.

Inflammation reaching the brain through the vagus nerve is one of several autonomic mechanisms that may disrupt sleep. This pathway may compound with other causes — hormonal shifts, metabolic fluctuations, or circadian misalignment — making the pattern harder to identify from symptoms alone.

Find out which causes might be driving your 3am wakeups →

Frequently Asked Questions

Does One Night of Poor Sleep Cause Inflammation?

A single night of total or partial sleep deprivation does not significantly change inflammatory markers like IL-6 or C-reactive protein. A 2026 meta-analysis of 887 healthy adults found that it takes three or more consecutive nights of restricted sleep before inflammatory markers measurably rise.

Ballesio et al. (2026) examined 35 experimental studies and found that single-night total sleep deprivation produced no significant changes in any inflammatory marker examined — including IL-6, TNF-alpha, and CRP. Only multiple nights of partial sleep deprivation (approximately 4.3 hours per night for three or more consecutive nights) significantly elevated IL-6 (Cohen’s d=0.42) and CRP (d=0.76). The dose-response pattern parallels animal vagal signaling thresholds: sustained moderate cytokine elevation — not a single acute spike — is what activates vagal afferents and triggers the NTS-mediated sleep disruption cascade in animal models. One bad night does not start the inflammation-sleep loop, but three consecutive restricted nights can initiate it.

Is the Vagus Nerve the Only Way Inflammation Reaches the Brain?

No. At high cytokine concentrations — such as during severe infection or sepsis — inflammatory signals reach the brain through the bloodstream via circumventricular organs that lack a complete blood-brain barrier. The vagus nerve is the primary route for low-grade, chronic inflammation — the kind most people experience during conditions like gut permeability or metabolic dysfunction.

The dose-dependent dual pathway was established in two vagotomy studies. Kubota et al. (2001) showed that 200 micrograms per kilogram of TNF-alpha produced similar NREM sleep enhancement in vagotomized and sham-operated rats — meaning that dose bypassed the vagal route entirely and reached the brain through the bloodstream. Hansen and Krueger (1997) demonstrated the same principle with IL-1-beta: at 2.5 micrograms per kilogram, NREM sleep and fever responses were virtually identical whether the vagus nerve was intact or severed. The transition point between vagal dominance and humoral dominance falls at cytokine concentrations well above what chronic low-grade inflammation produces. For the type of peripheral inflammation most commonly linked to insomnia — gut-derived, metabolic, or autoimmune in origin — the vagus nerve remains the dominant relay to the brain.

Can Gut Inflammation Specifically Disrupt Sleep Through the Vagus Nerve?

Yes. The vagus nerve’s largest sensory branch innervates the gut, making it the primary conduit for gut-derived inflammatory signals. When IL-1-beta was injected into the abdominal cavity in animal studies, subdiaphragmatic vagotomy completely blocked its sleep-altering and fever-inducing effects at physiological doses.

Hansen and Krueger (1997) used subdiaphragmatic vagotomy specifically — severing the vagal branches below the diaphragm that innervate the abdominal organs. At 0.1 micrograms per kilogram of IL-1-beta administered intraperitoneally, NREM sleep increases and fever were fully blocked in vagotomized animals while intact animals showed both responses. The subdiaphragmatic vagus is the primary conduit for abdominal immune activation to drive CNS sickness responses, including sleep disruption. This finding has direct relevance to conditions involving local gut inflammation — irritable bowel syndrome, inflammatory bowel disease, and gut dysbiosis — where cytokines produced in the intestinal environment activate vagal afferents that terminate in the NTS and alter sleep architecture without requiring systemic cytokine elevation detectable in blood tests.

What Is the Nucleus Tractus Solitarius and Why Does It Matter for Sleep?

The nucleus tractus solitarius is the brainstem relay station where all vagal sensory information arrives. From the NTS, signals project to the hypothalamus, limbic structures, and sleep-regulatory regions. When vagal immune signals arrive at the NTS, they activate neural pathways that alter sleep architecture — increasing NREM sleep pressure and fragmenting sleep continuity.

The NTS is not a passive relay point. Maier et al. (1998) established that the NTS receives vagal afferent terminals carrying cytokine information and projects to the hypothalamus and limbic structures — the anatomical substrate for translating peripheral immune signals into coordinated behavioral and physiological sickness responses including sleep changes. Hofmann et al. (2024) demonstrated that the NTS actively remodels after vagal injury: presynaptic calcium channel reduction and postsynaptic NMDA receptor downregulation change how remaining vagal signals are processed. This is not simple denervation but active synaptic plasticity that alters NTS function long-term. The implication for chronic vagal dysfunction — whether from surgical vagotomy, autonomic neuropathy, or conditions like diabetes that damage small nerve fibers — is that NTS signal processing may degrade permanently, altering immune-to-brain communication and downstream sleep regulation even if partial vagal recovery occurs.

Does Chronic Inflammation Desensitize the Vagal Relay?

Emerging evidence suggests it may. A 2025 study using calcium imaging of vagal neurons in mice with colitis found that chronic gut inflammation increased baseline neural activity but decreased responsiveness to specific cytokine challenges. The vagal neurons also downregulated cytokine signaling pathways — suggesting the relay becomes less precise over time under sustained inflammatory conditions.

Huerta et al. (2025) induced colitis in mice using DSS (dextran sodium sulfate) and then performed calcium imaging of nodose ganglion neurons. Chronically inflamed mice showed increased baseline neuronal activity (P=0.0033) but paradoxically decreased responsiveness to specific cytokine challenges compared to healthy controls (P=0.0003 to P=0.0062 across measures). Transcriptomic analysis of inflamed nodose ganglia revealed downregulation of cytokine signaling pathways and upregulation of neuronal activity pathways. The vagal relay under chronic inflammation becomes noisier (higher baseline firing) but less discriminating (reduced ability to detect and differentiate specific cytokines). The relay does not simply become overactive — it becomes impaired in its ability to accurately report immune status to the brain. This may explain why chronic inflammatory conditions often produce unpredictable or treatment-resistant sleep disruption: the vagal relay itself has been degraded by sustained exposure to the signals it evolved to detect.

References

Ballesio, A., Fiori, V., & Lombardo, C. (2026). Effects of experimental sleep deprivation on peripheral inflammation: An updated meta-analysis of human studies. Journal of Sleep Research, 35(1), e70099. https://pubmed.ncbi.nlm.nih.gov/40474574/

Hansen, M. K., & Krueger, J. M. (1997). Subdiaphragmatic vagotomy blocks the sleep- and fever-promoting effects of interleukin-1beta. The American Journal of Physiology, 273(4), R1246-R1253. https://pubmed.ncbi.nlm.nih.gov/9362287/

Hofmann, G. C., Gama de Barcellos Filho, P., Khodadadi, F., Ostrowski, D., Kline, D. D., & Hasser, E. M. (2024). Vagotomy blunts cardiorespiratory responses to vagal afferent stimulation via pre- and postsynaptic effects in the nucleus tractus solitarii. The Journal of Physiology, 602(6), 1147-1174. https://pubmed.ncbi.nlm.nih.gov/38377124/

Huerta, T. S., Chen, A. C., Chaudhry, S., Tynan, A., Morgan, T., Park, K., Adamovich-Zeitlin, R., Haider, B., Li, J. H., Nagpal, M., Zanos, S., Pavlov, V. A., Brines, M., Zanos, T. P., Chavan, S. S., Tracey, K. J., & Chang, E. H. (2025). Neural representation of cytokines by vagal sensory neurons. Nature Communications, 16(1), 3840. https://pubmed.ncbi.nlm.nih.gov/40268933/

Irwin, M. R., Olmstead, R., Bjurstrom, M. F., Finan, P. H., & Smith, M. T. (2023). Sleep disruption and activation of cellular inflammation mediate heightened pain sensitivity: A randomized clinical trial. Pain, 164(5), 1128-1137. https://pubmed.ncbi.nlm.nih.gov/36314570/

Jin, H., Li, M., Jeong, E., Castro-Martinez, F., & Zuker, C. S. (2024). A body-brain circuit that regulates body inflammatory responses. Nature, 630(8017), 695-703. https://pubmed.ncbi.nlm.nih.gov/38692285/

Kubota, T., Fang, J., Guan, Z., Brown, R. A., & Krueger, J. M. (2001). Vagotomy attenuates tumor necrosis factor-alpha-induced sleep and EEG delta-activity in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 280(4), R1213-R1220. https://pubmed.ncbi.nlm.nih.gov/11247847/

Maier, S. F., Goehler, L. E., Fleshner, M., & Watkins, L. R. (1998). The role of the vagus nerve in cytokine-to-brain communication. Annals of the New York Academy of Sciences, 840, 289-300. https://pubmed.ncbi.nlm.nih.gov/9629257/

Schiweck, C., Sausmekat, S., Zhao, T., Jacobsen, L., Reif, A., & Edwin Thanarajah, S. (2024). No consistent evidence for the anti-inflammatory effect of vagus nerve stimulation in humans: A systematic review and meta-analysis. Brain, Behavior, and Immunity, 116, 237-258. https://pubmed.ncbi.nlm.nih.gov/38070618/

Zielinski, M. R., Dunbrasky, D. L., Taishi, P., Souza, G., & Krueger, J. M. (2013). Vagotomy attenuates brain cytokines and sleep induced by peripherally administered tumor necrosis factor-alpha and lipopolysaccharide in mice. Sleep, 36(8), 1227-1238, 1238A. https://pubmed.ncbi.nlm.nih.gov/23904683/

Written by Kat Fu, M.S., M.S. · Last reviewed: May 2026 · 10 references cited